118 related articles for article (PubMed ID: 12823628)
21. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.
Barouch DH; O'Brien KL; Simmons NL; King SL; Abbink P; Maxfield LF; Sun YH; La Porte A; Riggs AM; Lynch DM; Clark SL; Backus K; Perry JR; Seaman MS; Carville A; Mansfield KG; Szinger JJ; Fischer W; Muldoon M; Korber B
Nat Med; 2010 Mar; 16(3):319-23. PubMed ID: 20173752
[TBL] [Abstract][Full Text] [Related]
22. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
23. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
24. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
Macatonia SE; Patterson S; Knight SC
Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
[TBL] [Abstract][Full Text] [Related]
25. Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.
Dubey S; Clair J; Fu TM; Guan L; Long R; Mogg R; Anderson K; Collins KB; Gaunt C; Fernandez VR; Zhu L; Kierstead L; Thaler S; Gupta SB; Straus W; Mehrotra D; Tobery TW; Casimiro DR; Shiver JW
J Acquir Immune Defic Syndr; 2007 May; 45(1):20-7. PubMed ID: 17310936
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
[TBL] [Abstract][Full Text] [Related]
27. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Sailaja G; Husain S; Nayak BP; Jabbar AM
J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275
[TBL] [Abstract][Full Text] [Related]
28. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
Zurawski G; Zurawski S; Flamar AL; Richert L; Wagner R; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Bonnabau H; Klucar P; Wang Z; Foulds KE; Kao SF; Yates NL; LaBranche C; Jacobs BL; Kibler K; Asbach B; Kliche A; Salazar A; Reed S; Self S; Gottardo R; Galmin L; Weiss D; Cristillo A; Thiebaut R; Pantaleo G; Levy Y
PLoS One; 2016; 11(4):e0153484. PubMed ID: 27077384
[TBL] [Abstract][Full Text] [Related]
29. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
[TBL] [Abstract][Full Text] [Related]
30. Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
Asbach B; Kliche A; Köstler J; Perdiguero B; Esteban M; Jacobs BL; Montefiori DC; LaBranche CC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Landucci G; Forthal DN; Seaman MS; Hawkins N; Self SG; Sato A; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Francis J; Galmin L; Ding S; Heeney JL; Pantaleo G; Wagner R
J Virol; 2016 Apr; 90(8):4133-4149. PubMed ID: 26865719
[TBL] [Abstract][Full Text] [Related]
31. DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques.
Cherpelis S; Jin X; Gettie A; Ho DD; Barnett SW; Shrivastava I; Stamatatos L
Immunol Lett; 2001 Nov; 79(1-2):47-55. PubMed ID: 11595289
[TBL] [Abstract][Full Text] [Related]
32. Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins.
Vogt G; le Grand R; Vaslin B; Boussin F; Auboyer MH; Rivière Y; Putkonen P; Sonigo P; Kieny MP; Girard M
Vaccine; 1995 Feb; 13(2):202-8. PubMed ID: 7625117
[TBL] [Abstract][Full Text] [Related]
33. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.
Reimann KA; Parker RA; Seaman MS; Beaudry K; Beddall M; Peterson L; Williams KC; Veazey RS; Montefiori DC; Mascola JR; Nabel GJ; Letvin NL
J Virol; 2005 Jul; 79(14):8878-85. PubMed ID: 15994781
[TBL] [Abstract][Full Text] [Related]
34. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation.
Wang B; Boyer J; Srikantan V; Ugen K; Gilbert L; Phan C; Dang K; Merva M; Agadjanyan MG; Newman M
Virology; 1995 Aug; 211(1):102-12. PubMed ID: 7645204
[TBL] [Abstract][Full Text] [Related]
35. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev.
MacGregor RR; Ginsberg R; Ugen KE; Baine Y; Kang CU; Tu XM; Higgins T; Weiner DB; Boyer JD
AIDS; 2002 Nov; 16(16):2137-43. PubMed ID: 12409734
[TBL] [Abstract][Full Text] [Related]
36. Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques.
Borgne SL; Michel ML; Camugli S; Corre B; Le Grand R; Rivière Y
Vaccine; 2001 Mar; 19(17-19):2485-95. PubMed ID: 11257382
[TBL] [Abstract][Full Text] [Related]
37. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
[TBL] [Abstract][Full Text] [Related]
38. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
39. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.
Chen X; Rock MT; Hammonds J; Tartaglia J; Shintani A; Currier J; Slike B; Crowe JE; Marovich M; Spearman P
J Virol; 2005 May; 79(9):5537-47. PubMed ID: 15827168
[TBL] [Abstract][Full Text] [Related]
40. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney J; Seaman M; Montefiori DC; Labranche C; Yates NL; Shen X; Tomaras GD; Ferrari G; Foulds KE; McDermott A; Kao SF; Roederer M; Hawkins N; Self S; Yao J; Farrell P; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo A; Weiss D; Lee C; Kibler K; Jacobs B; Asbach B; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2015 Aug; 89(16):8525-39. PubMed ID: 26041302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
